1. Peptidoglycan‐treated tumor antigen‐pulsed dendritic cells impart complete resistance against tumor rechallenge. (26th June 2020) Authors: Patidar, A.; Selvaraj, S.; Chauhan, P.; Guzman, C. A.; Ebensen, T.; Sarkar, A.; Chattopadhyay, D.; Saha, B. Journal: Clinical and experimental immunology Issue: Volume 201:Number 3(2020) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes. Issue 52 (15th December 2017) Authors: Landi, A.; Law, J.; Hockman, D.; Logan, M.; Crawford, K.; Chen, C.; Kundu, J.; Ebensen, T.; Guzman, C.A.; Deschatelets, L.; Krishnan, L.; Tyrrell, D.L.J.; Houghton, M. Journal: Vaccine Issue: Volume 35:Issue 52(2017) Page Start: 6949 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗